A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Clinical trial NCT06132893 · RECRUITING
Trial details
- NCT number
- NCT06132893
- Sponsor
- Biohaven Therapeutics Ltd.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-14
- Primary completion
- 2026-12-01
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.